Kiar Pharmaceutical Private Limited
About Kiar Pharmaceutical Private Limited
Data last updated:
Kiar Pharmaceutical Private Limited is a private limited company based in Dombivali, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2021PTC362000.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prasad D Umbargikar and Sameer Baburao Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/604 Navkar Apartment Patharli Road Opp Saibaba Nagar Shivaji Udyog Nagar, Dombivali, Maharashtra, India – 421201.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.69 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹40,581 (net margin 3%) and EBITDA of ₹62,222 (EBITDA margin 4.5%).
As per MCA filings, the company has open charges of ₹1 Cr on record.
Company details
Contact details
Kiar Pharmaceutical Private Limited's registered office is in Dombivali, Maharashtra.
- Registered AddressB/604 Navkar Apartment Patharli Road Opp Saibaba Nagar Shivaji Udyog Nagar, Dombivali, Maharashtra, India – 421201
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kiar Pharmaceutical Private Limited
FY 2025 filings availableKiar Pharmaceutical Private Limited reported revenue of ₹13.69 Lakh (down 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year. EBITDA fell 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹62,222 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹40,581 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.5% | |||
| Net Profit Margin | 3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kiar Pharmaceutical Private Limited, buy the company report.
Board of directors of Kiar Pharmaceutical Private Limited
Kiar Pharmaceutical has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Kumar Jain Also directs: Magis Pro Healthcare LLP, Cochlea Packaging Solutions LLP | Additional Director | 06 Nov 2025 | 0 Years 11 Months | Current |
| Prasad D Umbargikar Also directs: Sciref Greenovation LLP | Director | 11 Jun 2021 | 5 Years 4 Months | Current |
| Sameer Baburao Patil | Director | 11 Jun 2021 | 5 Years 4 Months | Current |
| Parmeshwar Annasaheb Lambud | Additional Director | 06 Nov 2025 | 0 Years 11 Months | Current |
| Kaustubh Arun Shisode Also directs: Skyan Infra LLP | Director | 15 Jan 2025 | 1 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Feb 2022 | 100558905 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Kiar Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kiar Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kiar Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kiar Pharmaceutical Private Limited has 7 board changes on record since 2021: 5 appointments and 2 cessations. The latest: Girish Kumar Jain was appointed as Additional Director on 06 Nov 2025.
Frequently asked questions
Kiar Pharmaceutical is an active private limited company based in Dombivali, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 June 2021 (5+ years old) and is registered under CIN U24230MH2021PTC362000.
Kiar Pharmaceutical has 5 current directors:
- Girish Kumar Jain - Additional Director
- Prasad D Umbargikar - Director
- Sameer Baburao Patil - Director
- Parmeshwar Annasaheb Lambud - Additional Director
- Kaustubh Arun Shisode - Director
The latest financial statements of Kiar Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Kiar Pharmaceutical is U24230MH2021PTC362000. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kiar Pharmaceutical was incorporated on 11 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Girish Kumar Jain was appointed as Additional Director on 06 Nov 2025. Parmeshwar Annasaheb Lambud was appointed as Additional Director on 06 Nov 2025. Kaustubh Arun Shisode ceased to be Additional Director on 29 Sep 2025. Kiar Pharmaceutical has 7 board changes on record in total.
The registered office of Kiar Pharmaceutical is at B604 Navkar Apartment Patharli Road Opp Saibaba Nagar Shivaji Udyog Nagar, Dombivali, Maharashtra, India – 421201.
Kiar Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Kiar Pharmaceutical has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.
Kiar Pharmaceutical can be reached at its registered office: B604 Navkar Apartment Patharli Road Opp Saibaba Nagar Shivaji Udyog Nagar, Dombivali, Maharashtra, India – 421201.